Sildenafil Citrate
Product Images NDC 17856-8100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 17856-8100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (17856 8100 01)

Image 1 (17856 8100 01)
Label for Sildenafil 20 mg tablets, package containing 200 sachets with 1 tablet each. Manufactured by Rubicon Research Pvt Ltd and packaged by Unit Dose Solutions, Morrisville, NC. The label includes storage instructions to keep between 20°-25°C (68°-77°F) and warnings to keep medication out of reach of children. Marked with product NDC 17856-8100.*
FDA Label Image

Image 2 (17856 8100 02)

Image 2 (17856 8100 02)
Packaging label for Sildenafil Citrate 20 mg tablets, containing 2 tablets per unit. The label includes storage instructions for 20°-25°C, a barcode, batch and expiration dates, and identifies the labeler as Atlantic Biologicals Corp. It also notes packaging by Unit Dose Solutions and manufacturing by Rubicon Research Pvt Ltd.*
FDA Label Image

Image 3 (17856 8100 03)

Image 3 (17856 8100 03)
Label for Sildenafil 20 mg tablets by ATLANTIC BIOLOGICALS CORP. The packaging contains 3 tablets per unit and indicates a quantity of 200 sachets. Storage instructions specify 20°-25°C (68°-77°F) controlled room temperature. The label includes batch, expiration (01/29/20), and packaging details from Unit Dose Solutions and manufacturer Rubicon Research Pvt Ltd.*
FDA Label Image

Image 4 (17856 8100 04)

Image 4 (17856 8100 04)
Label for Sildenafil Citrate 20 mg tablets, packaged as a 4-tablet unit. The package label includes storage instructions to keep the medication between 20°-25°C, a quantity of 200 sachets, and manufacturing details listing Rubicon Research Pvt Ltd as the manufacturer and Unit Dose Solutions in Morrisville, NC as the packager. The label also displays the product NDC 17856-8100 and includes barcodes, a QR code, expiration date, and serial and lot numbers.*
FDA Label Image

Image 5 (17856 8100 05)

Image 5 (17856 8100 05)
Label for Sildenafil 20 mg tablets by ATLANTIC BIOLOGICALS CORP., package size of 5 tablets and 200 sachets. The label includes storage instructions at 20-25°C, manufacturer information (Rubicon Research Pvt Ltd), and packaging details from Unit Dose Solutions. It also features a QR code and barcode.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

Graph (Sildenafil Tablets Usp 20mg Figure 06)
A line chart showing estimated cumulative mortality rate (%) over time in years, comparing High Dose, Medium Dose, and Low Dose groups. The chart includes stepwise lines for each dose group with corresponding labels. A 'Number at Risk' table above the chart shows decreasing sample sizes over time for each dose group.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

Graph (Sildenafil Tablets Usp 20mg Figure 07)
A forest plot chart depicting fold changes with 90% confidence intervals for area under the curve (AUC) and maximum concentration (Cmax) of Sildenafil Citrate when coadministered with various interacting drugs. It includes recommendations regarding dose adjustments or coadministration for drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

Graph (Sildenafil Tablets Usp 20mg Figure 08)
A chart showing fold change and 90% confidence intervals for various interacting drugs with sildenafil citrate, measuring changes in parameters like INR AUC, INR Cmax, BT, AUC, and Cmax. The chart includes recommendations for dose adjustments, mostly indicating no dose adjustment, with a note that coadministration with ritonavir is not recommended. The horizontal axis represents the change relative to interacting drug alone, ranging from 0.5 to 2.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

Graph (Sildenafil Tablets Usp 20mg Figure 09)
A line graph depicting change from baseline in meters over a 12-week study period. The x-axis represents weeks 4, 8, and 12, and the y-axis shows the change from baseline in meters. Four treatment groups are compared: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID. Data points with error bars display variations among the groups over time.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

Graph (Sildenafil Tablets Usp 20mg Figure 10)
A forest plot showing placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg TID compared to placebo. The chart categorizes data by baseline walk distance, etiology of pulmonary arterial hypertension (PAH), functional capacity class, gender, age, mean pulmonary artery pressure (PAP), and pulmonary vascular resistance index (PVRI). Each category displays patient numbers and corresponding confidence intervals for the treatment effect.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

Graph (Sildenafil Tablets Usp 20mg Figure 11)
A Kaplan-Meier survival curve showing the percentage of subjects without a clinically worsening event over time by day from randomization. Two groups are compared: one treated with Sildenafil (dashed line) and one with placebo (solid line). The Sildenafil group maintains a higher percentage without worsening events throughout the 112-day period compared to the placebo group, as indicated in the legend.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

Graph (Sildenafil Tablets Usp 20mg Figure 12)
A line graph showing the mean change from baseline in meters over 12 weeks of study for Sildenafil Citrate at 1 mg, 5 mg, and 20 mg taken three times daily (TID). The vertical axis represents change from baseline in meters, and the horizontal axis indicates weeks 4, 8, and 12. Error bars depict the standard error for each treatment group at the three time points.*
FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

Structure Formula (Sildenafil Tablets Usp 20mg Structure)
Chemical structure of sildenafil citrate showing its molecular components and arrangement including the sulfonyl, piperazine, and purine-type ring system along with citrate counterions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.